File(s) not publicly available

A Response To: Sodium-Glucose Cotransporter-2 Inhibitors and Major Covid-19 Outcomes: Promising Mechanisms, Conflicting Data And Intriguing Clinical Decisions

media

posted on 2020-10-13, 10:29 authored by Antonio C. Bossi, Franco Forloni, Paolo L. Colombelli

There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Pleiotropic effects of SGLT2-i SGLT2-i in COVID-19 Sodium glucose cotransporter 2 inhibitors (SGLT2-i)

Licence

CC BY-NC 4.0